Related Business Topics
Latest Headlines
Reuters - Nov. 19, 2009, 7:03 AM
Novel pipeline continues to advance and show promise BRIDGEWATER, N.J.--(Business Wire)-- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) presented data from its pipeline programs at the 2009 EORTC-NCI-AACR (European Organization for Research and Treatment of ...
ABC News - Nov. 9, 2009, 9:44 AM
Enzon Pharmaceuticals Inc. said Monday it is selling most of its business to Italian drugmaker sigma-tau Group and will focus on its experimental cancer drugs and technologies. Enzon will get $300 million upfront, along with milestone payments of as much ...
Reuters - Nov. 9, 2009, 8:40 AM
* Deal for $300 mln in cash * Sale to sigma-tau Group Nov 9 (Reuters) - Enzon Pharmaceuticals Inc (ENZN.O) said it agreed to sell its specialty pharmaceutical business to Italy-based pharmaceutical company, sigma-tau Group, for $300 million in cash and ...
Forbes.com - Oct. 28, 2009, 12:43 PM
BusinessWire - Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) announced today that it will report its financial results for the quarter ended September 30, 2009, on Tuesday, November 3, 2009 at approximately 8:00 am Eastern Time (ET). The release will be ...
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
E
Enzon
A biopharmaceutical company that developing advanced therapeutics for life-threatening diseases through the application of its proprietary technologies, PEG-Modification and Single-Chain Antigen-Binding (SCA®) proteins.
www.enzon.com
A biopharmaceutical company that developing advanced therapeutics for life-threatening diseases through the application of its proprietary technologies, PEG-Modification and Single-Chain Antigen-Binding (SCA®) proteins.
www.enzon.com
